Inventor

THIEMERMANN CHRISTOPH

GB6 patents

⚠️ This page may combine multiple inventors who share the name “THIEMERMANN CHRISTOPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CSL BEHRING AG

1 patent

US7759315B2Jul 20, 2010

Treatment of inflammatory conditions of the intestine

CSL BEHRING AG89 citations93

QUEEN MARY & WESTFIELD COLLEGE UNIV OF LONDON

1 patent

US9603831B2Mar 28, 2017

Artemisinin and its derivatives for use in the treatment of kidney disease

QUEEN MARY & WESTFIELD COLLEGE UNIV OF LONDON8 citations79

THIEMERMANN CHRISTOPH

1 patent

US9623005B2Apr 18, 2017

Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions

THIEMERMANN CHRISTOPH7 citations76

ZLB BEHRING AG

1 patent

US6998388B1Feb 14, 2006

High density lipoprotein against organ dysfunction following haemorrhagic shock

ZLB BEHRING AG7 citations66

UNIV LONDON QUEEN MARY

1 patent

US9949948B2Apr 24, 2018

Artemisinin and its derivatives for use in the treatment of trauma haemorrhage and associated conditions

UNIV LONDON QUEEN MARY0 citations48

ASSIST PUBLIQUE HOPITAUX DE MARSEILLE

1 patent

US12411143B2Sep 9, 2025

CD146 and uses thereof as a biomarker and as a therapeutic target in the diagnosis and treatment of fibrosis

ASSIST PUBLIQUE HOPITAUX DE MARSEILLE0 citations32